STEMPOINT CAPITAL LP
CIK 1952142 · View on SEC EDGAR ↗
- Portfolio value
- $522.3M
- Positions
- 82
- As of
- March 31, 2026 Data as of Q1 2026
#3,399 of 8,643 by 13F value · top 39.3%
Portfolio value QoQ: -9.5% 13F does not disclose cash
- Top 10 holdings weight
- 41.40%
- Top 25 holdings weight
- 69.76%
- Positions above 1%
- 32
- Effective number of positions
- 36.7
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 45.26% Est. buys $246,226,259 · sells $295,283,054
Median holding: 1.5 quarters Tracked Q4 2024–Q2 2026 · 37.2% still held
- New positions
- 34
- Increased
- 19
- Decreased
- 30
- Closed
- 27
Put-notional exposure: 0.1% puts 13F reports option positions at underlying notional value — may include hedges, not necessarily bearish bets
On this page
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- High-conviction bets The holdings this manager is most concentrated in.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Sector breakdown
Healthcare
95.2%
Other/Unmapped
4.8%
Full portfolio 84 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics, Inc. - Common Stock | $38,231,574 | 6.66% | 1,223,019 | $34,028,349 | Up ×1 | ||
| ABVX Abivax SA - American Depositary Shares | $37,800,132 | 6.59% | 283,657 | $2,859,504 | Down ×2 | ||
| RVMD Revolution Medicines, Inc. - Common Stock | $29,954,125 | 5.22% | 159,943 | $2,565,413 | Down ×1 | ||
| ERAS Erasca, Inc. - Common Stock | $28,687,526 | 5.00% | 1,565,913 | $24,806,575 | Up ×1 | ||
| TYRA Tyra Biosciences, Inc. - Common Stock | $20,210,163 | 3.52% | 632,754 | $12,811,484 | Up ×1 | ||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $19,578,955 | 3.41% | 200,851 | $12,403,627 | Up ×3 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $17,605,886 | 3.07% | 346,914 | $3,359,116 | Down ×1 | ||
| MLYS Mineralys Therapeutics, Inc. - Common Stock | $16,260,468 | 2.83% | 602,686 | $1,811,258 | Up ×3 | ||
| BHVN Biohaven Ltd. Common Shares | $15,835,296 | 2.76% | 1,064,200 | $2,345,902 | Down ×1 | ||
| KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | $13,380,514 | 2.33% | 209,234 | Up ×1 | |||
| SRRK Scholar Rock Holding Corporation - Common Stock | $13,153,030 | 2.29% | 239,146 | $-37,751,953 | Down ×1 | ||
| ALKS Alkermes plc - Ordinary Shares | $12,994,746 | 2.26% | 248,015 | $10,148,549 | Up ×1 | ||
| Unknown issuer (CUSIP: 337185102) | $12,529,187 | 2.18% | 622,723 | Up ×1 | |||
| PRAX Praxis Precision Medicines, Inc. - Common Stock | $12,468,584 | 2.17% | 37,243 | $-5,660,081 | Down ×1 | ||
| ROIV Roivant Sciences Ltd. - Common Shares | $12,330,159 | 2.15% | 348,408 | $1,643,499 | Down ×3 | ||
| BIOA BioAge Labs, Inc. - Common Stock | $11,376,831 | 1.98% | 464,171 | $5,453,773 | Up ×1 | ||
| CGON CG Oncology, Inc. - Common stock | $11,321,746 | 1.97% | 159,349 | $-2,594,751 | Down ×1 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $11,083,593 | 1.93% | 116,461 | Up ×1 | |||
| IMVT Immunovant, Inc. - Common Stock | $10,654,585 | 1.86% | 276,527 | $-7,888,326 | Down ×1 | ||
| CELC Celcuity Inc. - Common Stock | $10,273,998 | 1.79% | 98,203 | $3,418,521 | Up ×1 | ||
| RLMD Relmada Therapeutics, Inc. - Common Stock | $10,103,844 | 1.76% | 1,460,093 | $5,945,877 | Up ×1 | ||
| CLYM Climb Bio, Inc. - Common Stock | $9,685,395 | 1.69% | 742,745 | Up ×1 | |||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $9,492,890 | 1.65% | 106,926 | $1,038,843 | Down ×1 | ||
| ZURA Zura Bio Limited - Class A Ordinary shares | $8,072,469 | 1.41% | 1,368,215 | $3,589,025 | Up ×1 | ||
| IFRX InflaRx N.V. - Common Stock | $7,231,291 | 1.26% | 3,228,255 | ||||
| SRZN Surrozen, Inc. - Common Stock | $7,087,983 | 1.24% | 273,140 | $1,379,056 | Up ×1 | ||
| AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | $6,902,100 | 1.20% | 384,304 | $-2,406,522 | Down ×1 | ||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $6,638,711 | 1.16% | 178,412 | $-1,426,638 | Down ×1 | ||
| OVID Ovid Therapeutics Inc. - Common Stock | $6,502,491 | 1.13% | 2,417,283 | Up ×1 | |||
| EQ Equillium, Inc. - Common Stock | $6,453,142 | 1.12% | 2,016,607 | ||||
| DFTX Definium Therapeutics, Inc. - Common Shares | $6,450,313 | 1.12% | 137,124 | $298,684 | Down ×1 | ||
| CYTK Cytokinetics, Incorporated - Common Stock | $6,440,620 | 1.12% | 75,603 | $-2,099,800 | Down ×2 | ||
| GLTO Galecto, Inc. - Common Stock | $5,623,206 | 0.98% | 216,194 | Up ×1 | |||
| IVA Inventiva S.A. - American Depository Shares | $5,391,490 | 0.94% | 1,426,320 | ||||
| IPSC Century Therapeutics, Inc. - Common Stock | $5,258,146 | 0.92% | 2,146,182 | Up ×1 | |||
| AURA Aura Biosciences, Inc. - Common Stock | $5,071,388 | 0.88% | 714,280 | Up ×1 | |||
| EYPT EyePoint, Inc. - Common Stock | $4,840,135 | 0.84% | 338,471 | $-5,610,613 | Down ×1 | ||
| ASMB Assembly Biosciences, Inc. - Common Stock | $4,681,987 | 0.82% | 170,378 | $-463,834 | Down ×1 | ||
| WHWK Whitehawk Therapeutics, Inc. - Common Stock | $4,676,349 | 0.81% | 1,021,037 | $1,435,526 | Up ×1 | ||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $4,591,887 | 0.80% | 76,075 | $-3,593,016 | Down ×2 | ||
| QURE uniQure N.V. - Ordinary Shares | $4,058,577 | 0.71% | 88,115 | $2,782,198 | Up ×2 | ||
| CMPS COMPASS Pathways Plc - American Depository Shares | $4,029,481 | 0.70% | 284,769 | ||||
| Unknown issuer (CUSIP: 05348Y105) | $3,884,560 | 0.68% | 118,000 | Up ×1 | |||
| MPLT MapLight Therapeutics, Inc. - Common Stock | $3,831,511 | 0.67% | 106,906 | $1,798,511 | Up ×1 | ||
| ALMS Alumis Inc. - Common Stock | $3,819,611 | 0.67% | 135,736 | $-1,237,728 | Down ×1 | ||
| AXSM Axsome Therapeutics, Inc. - Common Stock | $3,763,339 | 0.66% | 15,375 | Up ×1 | |||
| GLUE Monte Rosa Therapeutics, Inc. - Common Stock | $3,715,765 | 0.65% | 153,544 | ||||
| ACAD ACADIA Pharmaceuticals Inc. - Common Stock | $3,622,125 | 0.63% | 143,167 | $-1,777,394 | Down ×1 | ||
| SLDB Solid Biosciences Inc. - Common Stock | $3,584,212 | 0.62% | 358,780 | $2,177,310 | Up ×1 | ||
| PSNL Personalis, Inc. - Common Stock | $3,320,292 | 0.58% | 247,783 | Up ×1 | |||
| CBIO Crescent Biopharma, Inc. - Common Stock | $3,282,876 | 0.57% | 182,382 | Up ×1 | |||
| ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | $3,195,029 | 0.56% | 39,198 | Up ×1 | |||
| KOD Kodiak Sciences Inc - Common Stock | $2,955,973 | 0.52% | 75,872 | Up ×1 | |||
| PHVS Pharvaris N.V. - Ordinary Shares | $2,797,764 | 0.49% | 80,907 | $350,269 | Down ×1 | ||
| MNPR Monopar Therapeutics Inc. - Common Stock | $2,789,274 | 0.49% | 30,125 | Up ×1 | |||
| RAPP Rapport Therapeutics, Inc. - Common Stock | $2,774,472 | 0.48% | 66,582 | Up ×1 | |||
| NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | $2,629,491 | 0.46% | 77,589 | $-3,153,372 | Down ×1 | ||
| SION Sionna Therapeutics, Inc. - Common Stock | $2,614,150 | 0.46% | 59,426 | $1,149,261 | Up ×1 | ||
| ARQT Arcutis Biotherapeutics, Inc. - Common stock | $2,594,338 | 0.45% | 98,945 | $-7,154,602 | Down ×1 | ||
| CCCC C4 Therapeutics, Inc. - Common Stock | $2,445,436 | 0.43% | 523,648 | $1,253,425 | Up ×1 | ||
| SPRB Spruce Biosciences, Inc. - Common Stock | $2,234,952 | 0.39% | 41,388 | $1,819,326 | Up ×1 | ||
| Unknown issuer (CUSIP: 22978P205) | $2,114,362 | 0.37% | 66,995 | Up ×1 | |||
| GPCR Structure Therapeutics Inc. - American Depositary Shares | $2,049,013 | 0.36% | 38,178 | $-7,603,856 | Down ×2 | ||
| PTGX Protagonist Therapeutics, Inc. - Common Stock | $1,998,422 | 0.35% | 16,303 | $-5,651,194 | Down ×1 | ||
| HLXC Helix Acquisition Corp. III - Class A Ordinary Shares | $1,826,579 | 0.32% | 171,671 | $-1,272,505 | Down ×1 | ||
| BDSX Biodesix, Inc. - Common Stock | $1,578,500 | 0.28% | 70,000 | $563,442 | Down ×1 | ||
| TENX Tenax Therapeutics, Inc. - Common Stock | $1,400,772 | 0.24% | 96,273 | $-1,616,541 | Down ×1 | ||
| SABS SAB Biotherapeutics, Inc. - Common Stock | $1,336,261 | 0.23% | 342,631 | $-99,989 | Down ×1 | ||
| CALC CalciMedica, Inc. - Common Stock | $1,195,661 | 0.21% | 1,244,864 | Up ×1 | |||
| LBRX LB Pharmaceuticals Inc - Common Stock | $1,031,582 | 0.18% | 31,785 | $-201,418 | Down ×1 | ||
| CLRB Cellectar Biosciences, Inc. - Common Stock | $986,728 | 0.17% | 354,938 | Up ×1 | |||
| PSNL Personalis, Inc. - Common Stock | $810,750 | 0.14% | 470,000 | Call option | Up ×1 | ||
| PRQR ProQR Therapeutics N.V. - Ordinary Shares | $801,760 | 0.14% | 431,054 | Up ×1 | |||
| BHVN Biohaven Ltd. Common Shares | $525,000 | 0.09% | 500,000 | Call option | |||
| XBI XBI | $400,000 | 0.07% | 250,000 | Put option | |||
| AZN AstraZeneca PLC - American Depositary Shares | $180,000 | 0.03% | 25,000 | Call option | Up ×1 | ||
| XBI XBI | $178,000 | 0.03% | 400,000 | Call option | $13,750 | Up ×1 | |
| TNGX Tango Therapeutics, Inc. - Common Stock | $175,000 | 0.03% | 100,000 | Call option | Up ×1 | ||
| RVMD Revolution Medicines, Inc. - Common Stock | $127,500 | 0.02% | 30,000 | Put option | $-397,500 | Down ×1 | |
| ERAS Erasca, Inc. - Common Stock | $90,000 | 0.02% | 200,000 | Put option | Up ×1 | ||
| ARKG | $75,000 | 0.01% | 100,000 | Put option | Up ×1 | ||
| ROIV Roivant Sciences Ltd. - Common Shares | $40,000 | 0.01% | 100,000 | Put option | Up ×1 | ||
| VTGN Vistagen Therapeutics, Inc. - Common Stock | $17,276 | 0.00% | 616,749 | $-40,911 | |||
| AMGN Amgen Inc. - Common Stock | $15,000 | 0.00% | 15,000 | Put option | Up ×1 | ||
| No matches | |||||||
Conviction holdings
Positions increased for 3+ consecutive quarters.
Share counts are as reported in 13F filings (not split-adjusted)
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| KNSA | $13,380,514 | 209,234 | 2.33% |
| Unknown issuer (CUSIP: 337185102) | $12,529,187 | 622,723 | 2.18% |
| ORKA | $11,083,593 | 116,461 | 1.93% |
| CLYM | $9,685,395 | 742,745 | 1.69% |
| IFRX | $7,231,291 | 3,228,255 | 1.26% |
| OVID | $6,502,491 | 2,417,283 | 1.13% |
| EQ | $6,453,142 | 2,016,607 | 1.12% |
| GLTO | $5,623,206 | 216,194 | 0.98% |
| IVA | $5,391,490 | 1,426,320 | 0.94% |
| IPSC | $5,258,146 | 2,146,182 | 0.92% |
| AURA | $5,071,388 | 714,280 | 0.88% |
| CMPS | $4,029,481 | 284,769 | 0.70% |
| Unknown issuer (CUSIP: 05348Y105) | $3,884,560 | 118,000 | 0.68% |
| AXSM | $3,763,339 | 15,375 | 0.66% |
| GLUE | $3,715,765 | 153,544 | 0.65% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| SRRK | Trimmed | -796K | -$37.8M |
| TYRA | Bought more | +440K | +$12.8M |
| DNTH | Bought more | +115K | +$12.4M |
| ALKS | Bought more | +168K | +$10.1M |
| IMVT | Trimmed | -470K | -$7.9M |
| GPCR | Trimmed | -162K | -$7.6M |
| ARQT | Trimmed | -315K | -$7.2M |
| RLMD | Bought more | +863K | +$5.9M |
| PRAX | Trimmed | -19K | -$5.7M |
| PTGX | Trimmed | -56K | -$5.7M |
2 positions hidden (data completeness check)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| CNTA | March 31, 2026 | 1,229,114 | $28,890,641 | No longer tracked |
| SNDX | June 30, 2026 | 1,365,743 | $28,489,756 | -6.1% |
| ACLX | March 31, 2026 | 332,860 | $21,702,472 | No longer tracked |
| BHVN | Dec. 31, 2025 | 1,497,311 | $16,457,838 | 27.3% |
| CRNX | March 31, 2025 | 317,060 | $16,211,278 | 152.7% |
| WVE | Dec. 31, 2025 | 2,110,152 | $15,446,313 | -68.1% |
| MBX | June 30, 2026 | 499,469 | $14,909,150 | 20.9% |
| CDTX | Dec. 31, 2025 | 152,325 | $14,586,642 | No longer tracked |
| MRUS | Sept. 30, 2025 | 266,094 | $13,996,544 | No longer tracked |
| INCY | March 31, 2025 | 193,623 | $13,373,541 | 107.2% |
| RVMD | June 30, 2025 | 318,782 | $11,272,132 | 492.7% |
| MDGL | March 31, 2026 | 17,736 | $10,328,382 | 2.2% |
| PRAX | March 31, 2025 | 134,178 | $10,326,339 | 875.3% |
| ADPT | March 31, 2026 | 606,825 | $9,854,838 | 84.4% |
| PALI | March 31, 2026 | 4,192,375 | $9,852,081 | 23.4% |
| LEGN | Sept. 30, 2025 | 270,144 | $9,587,411 | -30.5% |
| GERN | Sept. 30, 2025 | 6,949,244 | $9,427,934 | 15.0% |
| BMY | March 31, 2025 | 166,068 | $9,392,806 | 11.5% |
| XENE | June 30, 2025 | 274,633 | $9,213,937 | 104.3% |
| ARGX | Dec. 31, 2025 | 12,465 | $9,193,685 | 21.2% |
| DYN | June 30, 2026 | 506,075 | $9,175,140 | 18.9% |
| EWTX | June 30, 2026 | 290,864 | $9,162,216 | 13.7% |
| ZLAB | Sept. 30, 2025 | 250,438 | $8,757,817 | -19.9% |
| RZLT | Dec. 31, 2025 | 917,630 | $8,625,722 | 104.0% |
| DNLI | June 30, 2026 | 426,561 | $8,189,971 | -2.6% |
| GHRS | Dec. 31, 2025 | 545,275 | $7,797,433 | 135.2% |
| DRUG | March 31, 2026 | 97,340 | $7,596,414 | 17.0% |
| NKTR | March 31, 2026 | 178,274 | $7,537,425 | 5.5% |
| ALKS | Dec. 31, 2025 | 241,637 | $7,249,110 | 81.2% |
| CGON | June 30, 2025 | 289,823 | $7,101,533 | 201.9% |
| SWTX | June 30, 2025 | 159,305 | $7,030,130 | No longer tracked |
| IOVA | March 31, 2025 | 949,401 | $7,025,567 | 128.7% |
| BNTX | March 31, 2025 | 61,403 | $6,996,872 | 23.8% |
| BBIO | Dec. 31, 2025 | 127,435 | $6,618,974 | 10.7% |
| CLPT | March 31, 2026 | 481,858 | $6,591,817 | 74.3% |
| IMTX | March 31, 2026 | 610,308 | $6,408,234 | -6.2% |
| OCUL | March 31, 2026 | 522,693 | $6,345,493 | 34.9% |
| RYTM | March 31, 2026 | 58,915 | $6,306,262 | 35.1% |
| INSM | Dec. 31, 2025 | 43,419 | $6,251,468 | -26.0% |
| APGE | March 31, 2026 | 80,574 | $6,081,726 | 60.1% |
| INCY | March 31, 2026 | 61,435 | $6,067,935 | 33.3% |
| CYTK | June 30, 2025 | 149,648 | $6,014,353 | 132.1% |
| AKRO | Dec. 31, 2025 | 136,910 | $5,774,235 | No longer tracked |
| IDYA | March 31, 2026 | 161,659 | $5,588,552 | 16.6% |
| BPMC | June 30, 2025 | 61,927 | $5,481,159 | No longer tracked |
| LENZ | Sept. 30, 2025 | 183,912 | $5,390,461 | -89.3% |
| SLRN | March 31, 2025 | 1,704,825 | $5,353,151 | No longer tracked |
| MAZE | March 31, 2026 | 125,877 | $5,215,084 | -0.3% |
| JAZZ | Dec. 31, 2025 | 39,072 | $5,149,690 | 50.0% |
| LLY | March 31, 2026 | 4,759 | $5,114,402 | 40.0% |
| TRVI | March 31, 2026 | 399,557 | $5,002,454 | 57.8% |
| RNA | Dec. 31, 2025 | 114,053 | $4,969,289 | -81.8% |
| NRIX | June 30, 2026 | 315,226 | $4,886,003 | 13.3% |
| VRDN | March 31, 2026 | 154,320 | $4,802,438 | 25.1% |
| ABUS | March 31, 2026 | 986,751 | $4,746,272 | 11.3% |
| MLTX | March 31, 2026 | 348,401 | $4,591,925 | -11.8% |
| NUVL | Sept. 30, 2025 | 59,828 | $4,564,876 | No longer tracked |
| NMRA | March 31, 2025 | 428,137 | $4,538,252 | 66.0% |
| CTMX | March 31, 2026 | 1,036,311 | $4,414,685 | -25.1% |
| EVMN | June 30, 2026 | 193,777 | $4,385,357 | 10.7% |
| EYPT | March 31, 2025 | 579,500 | $4,317,275 | 10.0% |
| RARE | March 31, 2025 | 101,809 | $4,283,105 | -27.1% |
| ETNB | March 31, 2025 | 545,800 | $4,268,156 | No longer tracked |
| EWTX | June 30, 2025 | 230,255 | $4,203,110 | 252.5% |
| SNSE | June 30, 2026 | 132,873 | $4,188,157 | No longer tracked |
| CTNM | March 31, 2025 | 265,833 | $3,894,453 | 114.6% |
| JNJ | June 30, 2026 | 15,415 | $3,768,043 | 8.5% |
| APGE | Sept. 30, 2025 | 84,466 | $3,668,358 | 239.2% |
| XFOR | June 30, 2026 | 850,742 | $3,513,564 | -8.1% |
| PCVX | June 30, 2026 | 59,061 | $3,432,035 | 7.1% |
| RCKT | March 31, 2025 | 270,983 | $3,406,256 | -46.9% |
| HLXB | Sept. 30, 2025 | 315,812 | $3,290,856 | No longer tracked |
| ASND | March 31, 2026 | 14,842 | $3,164,908 | 12.0% |
| EYPT | Sept. 30, 2025 | 329,254 | $3,098,280 | -58.1% |
| TECX | Dec. 31, 2025 | 188,999 | $2,965,394 | 75.2% |
| JSPR | March 31, 2025 | 135,244 | $2,891,517 | -82.3% |
| HROW | Dec. 31, 2025 | 57,619 | $2,776,083 | -15.0% |
| EQ | Dec. 31, 2025 | 1,908,935 | $2,729,777 | 52.9% |
| UTHR | Dec. 31, 2025 | 6,264 | $2,625,931 | 9.5% |
| RGEN | March 31, 2026 | 15,707 | $2,573,749 | 50.9% |
| TRML | March 31, 2025 | 126,400 | $2,563,392 | No longer tracked |
| CGON | Dec. 31, 2025 | 63,019 | $2,538,405 | 89.0% |
| QNCX | March 31, 2026 | 739,264 | $2,476,534 | 32464.4% |
| REGN | Sept. 30, 2025 | 4,672 | $2,452,800 | 49.5% |
| IVVD | June 30, 2026 | 1,874,546 | $2,436,910 | 4.9% |
| ELVN | June 30, 2025 | 120,430 | $2,370,062 | 194.0% |
| NBIX | June 30, 2025 | 21,052 | $2,328,351 | 23.7% |
| ASND | June 30, 2025 | 14,732 | $2,296,130 | 48.4% |
| MGTX | March 31, 2026 | 287,689 | $2,287,128 | 65.1% |
| QQQ | Dec. 31, 2025 | 3,797 | $2,279,605 | |
| SYRE | June 30, 2025 | 136,139 | $2,196,603 | 605.7% |
| FOLD | June 30, 2025 | 268,919 | $2,194,379 | No longer tracked |
| IVA | March 31, 2026 | 467,242 | $2,172,675 | -14.7% |
| JBIO | June 30, 2026 | 154,034 | $2,164,178 | 4.4% |
| ABBV | March 31, 2026 | 9,325 | $2,130,669 | 22.0% |
| JANX | Sept. 30, 2025 | 89,933 | $2,077,452 | -29.2% |
| TNGX | Dec. 31, 2025 | 245,378 | $2,061,175 | 194.3% |
| TWST | June 30, 2026 | 43,110 | $2,048,587 | 30.4% |
| AVTX | June 30, 2026 | 134,742 | $2,011,698 | 11.0% |
| ORIC | Dec. 31, 2025 | 166,461 | $1,997,532 | 75.4% |
| IONS | June 30, 2026 | 26,385 | $1,981,250 | -23.9% |
| IMCR | June 30, 2026 | 63,543 | $1,915,821 | 15.5% |
| PEPG | Dec. 31, 2025 | 389,189 | $1,798,053 | -55.5% |
| ADCT | March 31, 2026 | 502,570 | $1,774,072 | -72.3% |
| ABUS | June 30, 2025 | 467,882 | $1,632,908 | 62.1% |
| LEGN | March 31, 2026 | 73,328 | $1,594,151 | 25.3% |
| PCSC | Dec. 31, 2025 | 150,000 | $1,590,000 | No longer tracked |
| TARA | Dec. 31, 2025 | 363,666 | $1,581,947 | -23.5% |
| CMPS | Dec. 31, 2025 | 275,620 | $1,579,303 | 102.0% |
| PYXS | Dec. 31, 2025 | 689,538 | $1,530,774 | 193.9% |
| FBRX | June 30, 2026 | 58,020 | $1,502,718 | 262.0% |
| BLTE | March 31, 2026 | 9,163 | $1,465,713 | 3.5% |
| PRAX | Sept. 30, 2025 | 32,255 | $1,356,323 | 596.9% |
| VRNA | March 31, 2025 | 28,136 | $1,306,636 | No longer tracked |
| XLO | March 31, 2026 | 2,030,028 | $1,299,624 | 10.5% |
| LPCN | June 30, 2026 | 160,420 | $1,281,756 | -17.8% |
| CDTX | March 31, 2025 | 47,642 | $1,280,617 | No longer tracked |
| EW | June 30, 2026 | 24,588 | $1,169,207 | 2.2% |
| CAPR | June 30, 2026 | 37,592 | $1,142,797 | -68.0% |
| BBOT | March 31, 2026 | 86,517 | $1,083,193 | 5.0% |
| TSHA | March 31, 2026 | 182,130 | $1,001,715 | 43.4% |
| GLUE | March 31, 2026 | 61,577 | $965,527 | -3.2% |
| OCUL | June 30, 2025 | 124,523 | $912,754 | 23.2% |
| MNMD | Dec. 31, 2025 | 76,875 | $906,356 | No longer tracked |
| ENTA | Dec. 31, 2025 | 75,194 | $900,072 | -15.0% |
| DYN | June 30, 2025 | 84,430 | $883,138 | 177.4% |
| ZBIO | Dec. 31, 2025 | 38,742 | $860,072 | -12.8% |
| SLNO | June 30, 2025 | 11,155 | $797,025 | No longer tracked |
| IFRX | June 30, 2025 | 725,019 | $739,519 | 177.8% |
| SLDB | June 30, 2025 | 198,150 | $733,155 | 99.3% |
| ATYR | March 31, 2025 | 200,475 | $725,720 | -82.5% |
| CRVS | Dec. 31, 2025 | 96,439 | $710,755 | 101.7% |
| VRNA | Sept. 30, 2025 | 7,407 | $700,554 | No longer tracked |
| KALV | Dec. 31, 2025 | 56,770 | $691,459 | No longer tracked |
| ARCT | Dec. 31, 2025 | 35,606 | $656,219 | 62.3% |
| SION | June 30, 2025 | 60,000 | $627,600 | -64.9% |
| BCAX | June 30, 2025 | 47,078 | $613,426 | 181.7% |
| STRO | June 30, 2026 | 23,295 | $580,278 | -30.9% |
| VTYX | Dec. 31, 2025 | 167,470 | $520,832 | No longer tracked |
| VNDA | March 31, 2026 | 58,989 | $520,283 | -19.3% |
| QQQ | March 31, 2025 | 70,000 | $514,500 | |
| KTTA | March 31, 2026 | 355,082 | $458,056 | -33.8% |
| TECX | March 31, 2025 | 9,434 | $435,568 | 106.4% |
| ATAI | Dec. 31, 2025 | 76,032 | $402,209 | 78.5% |
| XBI | Dec. 31, 2025 | 700,000 | $280,000 | No longer tracked |
| SPY | March 31, 2025 | 35,000 | $214,025 | No longer tracked |
| CVS | June 30, 2025 | 64,100 | $165,058 | 38.6% |
| IONS | Dec. 31, 2025 | 50,000 | $137,500 | -23.7% |
| SPY | June 30, 2026 | 50,000 | $85,500 | No longer tracked |
| HIMS | March 31, 2025 | 75,000 | $75,000 | -1.8% |
| QQQ | June 30, 2026 | 40,000 | $74,200 | |
| CRSP | Dec. 31, 2025 | 40,000 | $59,000 | 8.4% |
| ARKG | Dec. 31, 2025 | 200,000 | $30,000 | No longer tracked |
| BBC | June 30, 2025 | 132,500 | $16,563 | No longer tracked |
| BSX | June 30, 2026 | 250,000 | $12,500 | 20.9% |
| MRK | June 30, 2025 | 151,700 | $8,344 | 91.2% |
| TERN | June 30, 2026 | 100,000 | $7,500 | No longer tracked |
| NVO | June 30, 2025 | 151,700 | $3,793 | -32.0% |
| OLMA | June 30, 2026 | 25,000 | $3,750 | -11.3% |